MINDCURE Announces Additional Equity Investment in ATMA; Kelsey Ramsden Named to ATMA Board of Directors Apr 8, 2021
MINDCURE Files Provisional Patent Application For iSTRYM, its Digital Therapeutics (DTx) SaaS Platform Mar 31, 2021
Pandemic Provides Opportunity for Evaluation of Mental Health; MindCure and MindMed Lead With Ibogaine Mar 8, 2021